Pfizer Inc (MIL:1PFE)
€ 25 -0.395 (-1.56%) Market Cap: 140.28 Bil Enterprise Value: 192.77 Bil PE Ratio: 36.11 PB Ratio: 1.64 GF Score: 63/100

Q1 2021 Pfizer Inc Earnings Call Transcript

May 04, 2021 / 02:00PM GMT
Operator

Good day, everyone, and welcome to Pfizer's First Quarter 2021 Earnings Conference Call. Today's call is being recorded.

At this time, I would like to turn the call over to Mr. Chuck Triano, Senior Vice President of Investor Relations. Please go ahead, sir.

Charles E. Triano
Pfizer Inc. - SVP of IR

Thank you, operator. Good morning, and thanks for joining us today to review Pfizer's first quarter 2020 results and financial guidance update as well as other relevant business topics. I'm joined today as usual by our Chairman and CEO, Dr. Albert Bourla; Frank D'Amelio, our CFO; Mikael Dolsten, President of Worldwide Research and Development and Medical; Angela Hwang, Group President, Pfizer Biopharmaceuticals Group; John Young, our Chief Business Officer; and Doug Lankler, General Counsel.

The slides and the accompanying remarks that will be presented on this call were posted to our website earlier this morning and are available at pfizer.com/investors. You'll see here, on Slide 3, our disclaimer regarding forward-looking statements we will make

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot